| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.1M | +15.7% |
| R&D Expense | $73.3M | +34.0% |
| SG&A Expense | $31.8M | +24.6% |
| Operating Income | -$105.3M | -16.2% |
| Pre-tax Income | -$95.2M | -45.2% |
| Income Tax | $1.2M | — |
| Net Income | -$96.5M | -47.2% |
| EPS (Basic) | -$0.54 | -45.9% |
| EPS (Diluted) | -$0.54 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.4M | -26.4% |
| Short-term Investments | $92.8M | -34.4% |
| Current Assets | $125.2M | -31.6% |
| Total Assets | $448.3M | -15.9% |
| Current Liabilities | $20.0M | +25.8% |
| Total Liabilities | $37.9M | +28.8% |
| Stockholders' Equity | $410.3M | -18.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.9M | -9.7% |
| Capital Expenditures | $15.9M | -53.8% |
| Investing Cash Flow | $64.2M | +51.1% |
| Financing Cash Flow | -$9.4M | -5550.3% |
| Free Cash Flow | -$79.8M | +13.9% |
| -45.9% |